How Pfizer is Responding to the Crisis in Ukraine

Pfizer has a cross-functional team of people dedicated to ensuring the safety of our colleagues and contractors based in Ukraine and offering continuous advice and support as best we can.
At this time, all colleagues have been accounted for and we remain in almost constant contact during this extremely challenging time.

We continue to work hard to ensure patients have access to the medicines and vaccines they need. We have established robust and preventative measures as well as flexible routes to help minimize impact on supply to Ukraine. We also continue to manage stock levels of critical medicines to ensure we can serve patients in the country. This is in addition to the millions of product donations we have facilitated with the Ukrainian government over the past year.

At the same time, we are continuing our collaboration with research partners in the region to mitigate impact to our clinical programs. In the interests of patient safety, we made the necessary decision when the conflict began to pause the recruitment of new participants to clinical trial programs. Instead, we have focused on maintaining continuity of care for those patients who are actively participating in the ongoing trials.

We are working with all our clinical trial sites in Ukraine to assist them however possible so they may continue to support patients and advance medical science. We are truly amazed at the resilience of the Ukrainian trial sites, healthcare professionals, patients, and all those involved—many of whom have continued their clinical trials as planned despite the challenging situation.

We are also working with the appropriate channels in the surrounding countries to connect with any displaced participants to facilitate their enrolment onto trial sites in their chosen location.

We will continue to evaluate the situation and adjust our approach as needed.

We have activated several humanitarian efforts and continue to expand our support, mostly through The Pfizer Foundation, a charitable organization founded by Pfizer Inc to address the challenges of a complex and evolving global health landscape.

Supporting global and local NGOs

As of February 2023, The Pfizer Foundation has committed $30 million to causes supporting the Ukrainian people. This includes grants derived from Pfizer’s decision to donate the equivalent of profits from our Russian subsidiary to causes that provide direct humanitarian support to the people of Ukraine.

The Foundation has approved grants for 15 non-governmental organizations (NGOs) and humanitarian organizations that are operating in Ukraine and surrounding countries to support humanitarian relief and response efforts. As part of these efforts The Pfizer Foundation worked with government and local community stakeholders to address priority humanitarian needs, including access to critical supplies such as gas and electricity, shelter, winterization, education and child protection. The Pfizer Foundation is also supporting efforts to restore health facilities and address immediate health needs for populations without access to essential care.

Our humanitarian relief partners:

• American Red Cross
• Crown Agents International Development, Ukraine
• International Medical Corps
• International Rescue Committee
• Leleka Foundation
• Polish Center for International Aid Foundation
• Polish Humanitarian Action
• Polish-Ukrainian Institute for Relief and Development
• Pirogov First Volunteer Mobile Hospital
• Save the Children
• Ukrainian Red Cross
• UNHCR
• UNICEF
• UNITED 24
• World Food Program

Collectively, these partners are on the front lines, supporting emergency relief priorities in Ukraine and the immediate needs of displaced populations in surrounding countries now hosting Ukrainian refugees.

Maximizing the generosity of Pfizer colleagues

Through The Pfizer Foundation, we have also launched the Ukraine Humanitarian Disaster Campaign matching financial donations already made by thousands of Pfizer colleagues around the world to UNICEF, the IRC, Save the Children, the American Red Cross, CARE, Nova Ukraine and Sunflower of Peace.

• As of February 2023, more than 4,300 colleagues from nearly 54 countries have donated nearly US $936,000. Including The Pfizer Foundation’s dollar-for-dollar match, the total donation is US $1.86 million.

Providing our medicines and vaccines to those that need them

Pfizer is also responding to the immediate need for access to life-saving medicines through targeted product donations to Ukraine and organisations supporting the Ukrainian people. This includes over 1,000,000 doses of Pfizer products, including lifesaving antibiotics, antifibrinolytics and oncology medicines to help healthcare providers and relief workers treat patients in Ukraine and neighbouring countries.

In partnership with the U.S. Government and USAID, almost 2 million donated doses of the Pfizer/BioNTech COVID-19 vaccine have also reached Ukraine.
We are also one of the largest donors to Direct Relief. As part of a broader product donation, we have delivered nearly 200,000 courses of Pfizer’s oral COVID-19 treatment to Ukraine.

*The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions